Neonatal Hypoxic Ischemic Encephalopathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2015-07-03
Clinical Trial Update: Melatonin Treatment for Newborn Infants With Moderate to Severe Hypoxic Ischemic Encephalopathy [Phase 1]
The Phase 1 clinical trial of melatonin for neonatal hypoxic-ischemic encephalopathy has been withdrawn.